Nucleic acid delivery using poly(ethylenimine)-based polymers for programmed death-ligand 1 (PD-L1) knockdown in ovarian cancer to enhance immunotherapy
Ovarian cancer remains the most lethal gynaecological cancer mainly due to the lack of reliable biomarkers and eventual development of chemo-resistance. This emphasizes the need for better therapies. Ovarian cancer is considered as an immunogenic tumour and adoptive immunotherapy is a promising trea...
Main Author: | Teo, Pei Yun |
---|---|
Other Authors: | Ghaem-Maghami, Sadaf |
Published: |
Imperial College London
2015
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.693999 |
Similar Items
-
Investigating the role of PD-L1 pathway in human ovarian cancer
by: Chatterjee, Jay
Published: (2014) -
Plasma membrane dynamics regulating the PD-1/PD-L1 Pathway
by: Bricogne, C. C.
Published: (2015) -
ROR1 as a target for cancer immunotherapy
by: Paredes Moscosso, Solange Rosa
Published: (2017) -
Circulating nucleic acids as biomarkers of breast cancer
by: Rghebi, Basma
Published: (2017) -
Micro-encapsulated poly(vinyl alcohol) nanoparticles for rifampicin delivery to the lungs
by: Sadouki, Fethi
Published: (2014)